Bone Biologics Corporation (BBLGW)

Market Cap	2.56M
Revenue (ttm)	n/a
Net Income (ttm)	-7.35M
Shares Out	2.46M
EPS (ttm)	-7.27
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,385
Open	5.07
Previous Close	59.22
Day's Range	16.00 - 20.80
52-Week Range	2.87 - 95.04
Beta	0.74
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 21, 2025

About BBLGW

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company’s NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company’s platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, ort...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 2
• Stock Exchange: NASDAQ
• Ticker Symbol: BBLGW
• Website: https://www.bonebiologics.com